Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Approved by the FDA, tirzepatide is changing the landscape of weight loss treatment by targeting the body's natural hormonal systems
Healthcare providers can help develop personalized approaches for those experiencing prolonged symptoms
Tirzepatide es un medicamento inyectable aprobado por la FDA para el tratamiento de la diabetes tipo 2 (bajo el nombre comercial Mounjaro) y para el manejo del peso en adultos con obesidad o sobrepeso con al menos una comorbilidad relacionada con el peso (como Zepbound)
Semaglutide GLP-1 helps in the reduction of body fat, resulting in progressive and healthy weight loss
Most patients notice reduced appetite and fewer cravings within the first 2 weeks
US$ 26.61
US$ 26.94
US$ 23.28
US$ 26.10
US$ 25.23
US$ 20.21
US$ 20.73
US$ 28.67
US$ 24.79
US$ 20.31
US$ 19.98
